Finance
EndoGastric Solutions completes $32 million series C financing
Published in Obesity and Diabetes Week, March 27th, 2006
The company plans to use the proceeds to support ongoing clinical trials, expand the product portfolio, and launch its first product commercially. In addition to Chicago Growth Partners, the company's existing investors, MPM Capital, Advanced Technology Ventures (ATV), and Foundation Medical Partners, participated with increased investments over previous rounds as did a new investor, Oakwood Medical Investors.
Dr....
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week
More Articles from Obesity and Diabetes Week
- Complementary & Alternative Medicine
Diacylglycerol oil supplements may be able to manage obesity in type 2 diabetics - Diet & Nutrition
Polyunsaturated fatty acids induce adiponectin and show antidiabetic properties - Insulin Sensitivity
IL-1 receptor antagonist upregulated in diet-induced obesity rodent model - Obesity Pathogenesis
Glucocorticoids exacerbate obesity and insulin resistance in neuron-specific Pomc-/- mice - Obesity Pathogenesis
High adiponectin levels seen in Prader-Willi syndrome as compared with other obesity types - Adverse Drug Reaction
13-cis-retinoic acid-induced reduction in insulin sensitivity raises fasting adiponectin levels - More from this issue of Obesity and Diabetes Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
